RELMADA THERAPEUTICS, INC. Stockholders' Equity, Other Shares
RELMADA THERAPEUTICS, INC. (RLMD) reported Stockholders' Equity, Other Shares of 166.48 thousand shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Shareholders' Equity
us-gaap:StockholdersEquityOtherShares · last filed 2022-11-10
- RELMADA THERAPEUTICS, INC. stockholders' equity, other shares for the quarter ending 2022-09-30 was 40.85K shares.
| Period end | Stockholders' Equity, Other Shares 3 month | Stockholders' Equity, Other Shares 6 month | Stockholders' Equity, Other Shares 9 month |
|---|---|---|---|
| 2022-09-30 | 40.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 166.48K shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 125.63K shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |